<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_EZ9K85Z">Enhancing tuberculosis treatment adherence and motivation through gamified realtime mobile app utilization: a single-arm intervention study</title>
				<funder>
					<orgName type="full">Joint TDR/World Health Organization Western Pacific Region Small Grant Scheme for Implementation Research</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nurhuda</forename><surname>Ismail</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Medicine , Faculty of Medicine , Universiti Teknologi MARA Sungai Buloh Campus , Sungai Buloh , Selangor 47000 , Malaysia</note>
								<orgName type="department" key="dep1">Department of Public Health Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Universiti Teknologi MARA Sungai Buloh Campus</orgName>
								<address>
									<addrLine>Sungai Buloh</addrLine>
									<postCode>47000</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Siti</forename><forename type="middle">Aishah</forename><surname>Abas</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Medicine , Faculty of Medicine , Universiti Teknologi MARA Sungai Buloh Campus , Sungai Buloh , Selangor 47000 , Malaysia</note>
								<orgName type="department" key="dep1">Department of Public Health Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Universiti Teknologi MARA Sungai Buloh Campus</orgName>
								<address>
									<addrLine>Sungai Buloh</addrLine>
									<postCode>47000</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yuslina</forename><surname>Zakaria</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Pharmaceutical Life Sciences , Faculty of Pharmacy , Universiti Teknologi MARA Puncak Alam Campus , Puncak Alam , Selangor 42300 , Malaysia</note>
								<orgName type="department" key="dep1">Department of Pharmaceutical Life Sciences</orgName>
								<orgName type="department" key="dep2">Faculty of Pharmacy</orgName>
								<orgName type="institution">Universiti Teknologi MARA Puncak Alam Campus</orgName>
								<address>
									<addrLine>Puncak Alam</addrLine>
									<postCode>42300</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Siti</forename><forename type="middle">Munira</forename><surname>Yasin</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Medicine , Faculty of Medicine , Universiti Teknologi MARA Sungai Buloh Campus , Sungai Buloh , Selangor 47000 , Malaysia</note>
								<orgName type="department" key="dep1">Department of Public Health Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Universiti Teknologi MARA Sungai Buloh Campus</orgName>
								<address>
									<addrLine>Sungai Buloh</addrLine>
									<postCode>47000</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Khalid</forename><surname>Ibrahim</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Medicine , Faculty of Medicine , Universiti Teknologi MARA Sungai Buloh Campus , Sungai Buloh , Selangor 47000 , Malaysia</note>
								<orgName type="department" key="dep1">Department of Public Health Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Universiti Teknologi MARA Sungai Buloh Campus</orgName>
								<address>
									<addrLine>Sungai Buloh</addrLine>
									<postCode>47000</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ismassabah</forename><surname>Ismail</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Centre of Foundation Studies , Universiti Teknologi MARA Cawangan Selangor , Kampus Dengkil , Dengkil , Selangor 43800 , Malaysia</note>
								<orgName type="department">Centre of Foundation Studies</orgName>
								<orgName type="institution">Universiti Teknologi MARA Cawangan Selangor</orgName>
								<address>
									<addrLine>Kampus Dengkil</addrLine>
									<postCode>43800</postCode>
									<settlement>Dengkil</settlement>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Asmah</forename><surname>Razali</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Disease Control Division , Sector TB/Leprosy , Ministry of Health , Putrajaya 62590 , Malaysia</note>
								<orgName type="department">Disease Control Division</orgName>
								<orgName type="institution" key="instit1">Sector TB/Leprosy</orgName>
								<orgName type="institution" key="instit2">Ministry of Health</orgName>
								<address>
									<postCode>62590</postCode>
									<settlement>Putrajaya</settlement>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mas</forename><forename type="middle">Ahmad</forename><surname>Sherzkawi</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> TB/Leprosy Disease Unit , Selangor State Health Department , Seksyen 9 , Shah Alam , Selangor 40100 , Malaysia</note>
								<orgName type="department">TB/Leprosy Disease Unit</orgName>
								<orgName type="institution">Selangor State Health Department</orgName>
								<address>
									<addrLine>Seksyen 9 Shah Alam</addrLine>
									<postCode>40100</postCode>
									<region>Selangor</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norliza</forename><surname>Ahmad</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> TB/Leprosy Disease Unit , Negeri Sembilan State Health Department , Jalan Rasah , Bukit Rasah , Negeri Sembilan , Seremban 70300 , Malaysia</note>
								<orgName type="department">TB/Leprosy Disease Unit</orgName>
								<orgName type="institution">Negeri Sembilan State Health Department</orgName>
								<address>
									<addrLine>Jalan Rasah Bukit Rasah Negeri Sembilan</addrLine>
									<postCode>70300</postCode>
									<settlement>Seremban</settlement>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_axPpppA">Enhancing tuberculosis treatment adherence and motivation through gamified realtime mobile app utilization: a single-arm intervention study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">6BA5F140D22C1D013C92DED9EA0B0DD1</idno>
					<idno type="DOI">10.1186/s12889-023-17561-z</idno>
					<note type="submission">Received: 7 September 2023 / Accepted: 21 December 2023</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T11:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_4yqvdHP">Video direct observe therapy (VDOT)</term>
					<term xml:id="_YFCaeeK">Mobile health (mHealth)</term>
					<term xml:id="_RZNsGFk">Tuberculosis</term>
					<term xml:id="_JmB6Xug">Medication adherence</term>
					<term xml:id="_KvkEF8w">Mobile application</term>
					<term xml:id="_bnK2ASX">Gamification</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_5fS5T5b"><p xml:id="_uNkHjxM"><s xml:id="_d8d2aTE">Background Finding innovative methods to enhance Tuberculosis treatment adherence in Malaysia is imperative, given the rising trend of non-adhere TB patients.</s><s xml:id="_CJqSPqc">Direct Observed Therapy (DOTS) has been used to ensure Tuberculosis (TB) drug compliance worldwide.</s><s xml:id="_J9J8KsA">However, due to its inconvenience, digitalizing this system into a virtual monitoring system via a mobile app can help deliver a more efficient tuberculosis management system.</s><s xml:id="_AGqrWpN">A gamified video-observed therapy is developed that connects three users the patient, supervisor, and administrator, allowing drug monitoring and patient loss to follow up with the patient tracking system.</s><s xml:id="_eK46GN2">Thus, the objective of this study is to determine the impact of Gamified Real-time Video Observed Therapy (GRVOTS) mobile apps on patient medication adherence rates and motivation.</s></p><p xml:id="_szppDtN"><s xml:id="_7krQQQe">Methods 71 patients from 18 facilities participated in the 8-week single-arm intervention study.</s><s xml:id="_CtUwfFP">GRVOTS mobile apps were installed in their mobile apps, and patients were expected to fulfill tasks such as providing Video Direct Observe Therapy (VDOTS) daily as well as side effect reporting.</s><s xml:id="_gp5XWPd">At 3-time intervals of baseline,1-month, and 2-month intervals, the number of VDOT taken, the Malaysian Medication Adherence Assessment Tool (MyMAAT), and the Intrinsic Motivation Inventory (IMI) questionnaire were collected.</s><s xml:id="_yJd2YjT">One-sample t-test was conducted comparing the VDOT video adherence to the standard rate of 80%.</s><s xml:id="_kyUWc5S">RM ANOVA was used to analyze any significant differences in MyMAAT and IMI scores across three-time intervals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zbVDc5K">Results</head><p xml:id="_yV6pHKr"><s xml:id="_axgFBu2">This study involved 71 numbers of patients from 18 healthcare facilities who showed a significantly higher treatment adherence score of 90.87% than a standard score of 80% with a mean difference of 10.87(95% CI: 7.29,14.46;</s><s xml:id="_xGEzUJM">p &lt; 0.001).</s><s xml:id="_P9JK4Yx">The participants' MyMAAT and IMI scores significantly increased over 3-time intervals with the IMI Interest domain showing the highest mean difference 19.76 (95% CI: 16.37,<ref type="bibr" target="#b20">21.</ref></s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5sJhhfj">Background</head><p xml:id="_zXEJ85W"><s xml:id="_EADHTwQ">Tuberculosis has stood as the most concerning global infectious disease for three decades, with over 10 million new cases reported annually worldwide <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_NUmmJzy">According to a model projection by <ref type="bibr">Ismail N. et al. (2013)</ref>, the observed and projected TB incidence cases in Malaysia from 1990 will reach up to 30,000 cases in 2030 <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_RWd7Xy5">After being diagnosed with Tuberculosis, patients are required to successfully finish a 6-month medication regimen utilizing Direct Observed Therapy Short Course (DOTS), a well-established method recognized globally for enhancing medication adherence in TB programs.</s><s xml:id="_jBhmmWU">Nevertheless, despite the introduction of physical DOTS in 1994, Malaysia has encountered persistent challenges with TB loss to follow-up prevelance fluctuating between 4.0% (2010) and 4.8% <ref type="bibr">(2015)</ref>, and more recently surging to 5.6%, as indicated by the most recent research data <ref type="bibr" target="#b2">[3]</ref>.</s></p><p xml:id="_Rkg2juR"><s xml:id="_2gZUvdM">Mobile health technology offers significant potential to improve the management of chronic infectious diseases like tuberculosis (TB).</s><s xml:id="_TvEfUYm">It addresses the critical challenge of ensuring patient adherence to complete treatment courses, vital in preventing TB spread and drug-resistant strains.</s><s xml:id="_6WDcSmJ">By fostering patient empowerment, self-management, and connecting patients with healthcare professionals, mobile health technology enhances disease management for TB and similar chronic infections <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s></p><p xml:id="_V976W7X"><s xml:id="_TyXVS79">In 2015, the World Health Organization published a roadmap outlining its strategy to integrate digital health into TB prevention and care, with a key focus on enhancing medication adherence support <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_UM3jhKX">Digitalization of TB physical DOTS to VDOT via mobile app systems could help with more efficient service delivery.</s><s xml:id="_rNhcwpP">However, among the few apps developed for use by TB patients, none were designed to support TB patients' involvement in and management of their care.</s><s xml:id="_4jEUhTC">In a scoping review regarding "The Use of Digital Technology to Enhance Tuberculosis Control", only three out of 145 studies of health apps look into healthcare providers' and patients' perspectives in their analysis <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_V9PBafd">It mainly focused on utilizing digital health technology feedback by health professionals rather than TB patients.</s><s xml:id="_at5M2Jp">One study even called for increased patient support focus after reviewing 24 TB health-related apps and argued that TB patient care apps had minimal functionality, were designed primarily for healthcare workers and were more focused on data collection <ref type="bibr" target="#b8">[9]</ref>.</s></p><p xml:id="_9Mbp6pw"><s xml:id="_YtJDuZx">Additionally, Abdul Rahim and Thomas (2017) emphasized the potential of gamification in improving treatment adherence, as evidenced in their study on using gamification to encourage medication adherence in epilepsy <ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_YnGSP7J">Their study demonstrated that a gamified approach to epilepsy treatment not only enhances patient adherence but also has the potential to positively influence public perceptions of the disease if shared with a broader audience.</s><s xml:id="_kCAMdbz">Game dynamics can improve user desire and motivation by establishing rules that encourage users to explore and learn about apps, thus maintaining usage sustainability <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_sjCQRmQ">With a balance of intrinsic and extrinsic rewards, gamification has the element of a design-thinking focused process to engage and motivate the audience into desired behaviors.</s><s xml:id="_Su2euQz">Thus, it has the potential to transform dull routine tasks into a more enjoyable and motivating experience and has proven to increase intrinsic motivation <ref type="bibr" target="#b11">[12]</ref>.</s></p><p xml:id="_dMF29XN"><s xml:id="_8ZuCXFe">Gamified-Real-Time Video Observed Therapy (GRV-OTS) is a mobile application specifically designed to bridge the gap in patient support by incorporating gamification, real-time features, and motivational elements to enhance medication adherence, motivate patients, and ensure continued engagement with the app <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_XjSwUTM">This paper aimed to document the concept of GRVOTS mobile apps and report its impact towards patients' motivation and treatment adherence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6AmpaBU">Methods GRVOTS mobile apps</head><p xml:id="_BSrZEfH"><s xml:id="_CcY6AWy">The GRVOTS mobile app is used by three types of users: patients, supervisors, and administrators, each with their own unique dashboard upon login.</s><s xml:id="_evVCsGz">Patients see information related to their medication, progress, side effects, and virtual video observations.</s><s xml:id="_tPCUuy4">Supervisors have access to VDOT verification and side effect reporting.</s><s xml:id="_uZHD5AQ">Administrators can manage user accounts and view patient lists.</s><s xml:id="_jgdVg6V">Data, including real-time VDOT and adverse effect reports, is collected and accessible to supervisors and the TB management team for clinical interventions.</s><s xml:id="_U4fayvk">Additionally, there's a website for supervisors and administrators to monitor patient status and activities, with the development process recently published <ref type="bibr" target="#b12">[13]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4F5cfNx">The intervention study -tools and data analysis</head><p xml:id="_cYDMr36"><s xml:id="_Jk7sbfR">A single-arm intervention study involves administering the intervention to a sample of individuals with a specific medical condition and tracking them over time to observe the resulting outcomes <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_9BzgNAG">Between September and November 2022, a cross-sectional research approach was used to investigate how patients utilized GRVOTS over two months.</s><s xml:id="_7Sadxmw">Data collection was carried out with two established tools: the Malaysian Medication Adherence Assessment Tool (MyMAAT), which assesses medication adherence habits, and The Intrinsic Motivation Inventory (IMI), a questionnaire based on self-determination theory designed to measure intrinsic motivation levels.</s><s xml:id="_Ntj4Gun">Data collection involved the use of a self-administered questionnaire, and the gathered information was recorded in an Excel format.</s><s xml:id="_gXv2hD6">One-sample t-test was conducted comparing the VDOT video adherence to the standard rate of 80%.</s><s xml:id="_TTrtqd7">RM ANOVA was used to analyze any significant differences in MyMAAT and IMI scores across three-time intervals.</s><s xml:id="_kJF7btg">Data analysis was performed using Excel and exported to the Statistical Package for Social Science Software (SPSS version 28).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QCtFFUx">Participants and recruitment</head><p xml:id="_Ad6WxUJ"><s xml:id="_R4SM33Y">The population of this study included patients selected from the 18 facilities consisting of two government hospitals and another 16 primary health clinics.</s><s xml:id="_augJPBf">Eligible patients were those who were able to speak and read English or BM, working-aged TB patients (19-64 years old), newly diagnosed with pulmonary TB (firstline treatment), who completed the in-person DOTS at least two weeks (ensuring medication tolerance), were able to provide informed consent and were knowledgeable in smartphone and app usage.</s><s xml:id="_XQHGhrq">We excluded patients with drug-resistant TB and patients with health conditions that disallow them from using a smartphone (severe arthritis, vision impairment).</s></p><p xml:id="_4esZvE3"><s xml:id="_cGDvxpu">Participants who fit the recruitment criteria were offered mobile apps during their clinic visit.</s><s xml:id="_RW7E5gM">The informed consent form clearly explained that study participation was voluntary, and participants could withdraw from the study at any time without jeopardizing their health care.</s><s xml:id="_7cTPQ7q">Their decision to withdraw had no impact on their relationship with their treatment center.</s><s xml:id="_S3QMc58">If they wished to withdraw from study participation, they needed only to inform the principal investigator (PI), and no further data would be collected from that time onward.</s></p><p xml:id="_GSsGhnp"><s xml:id="_nTF6Gdj">Sample size estimation was calculated using the pairwise comparison formula.</s><s xml:id="_cjM4f7C">Preliminary data indicate that the control mean was 2.54 (SD:0.89)</s><s xml:id="_FR59AfP">compared to intervention 3.41 (SD 0.89).</s><s xml:id="_Buw26FC">If the type 1 error probability and precision are 0.05, we will need to study 55 samples.</s><s xml:id="_MESMYTA">We managed to recruit 88 patients from 18 health facilities and analyzed 17 patients lost to follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_j44tHhP">Procedure</head><p xml:id="_zZdxgDq"><s xml:id="_UBBbJjB">Each participant was asked to sign a consent form and complete a brief demographic questionnaire, including smartphone experience.</s><s xml:id="_KVYWwf2">The app was then downloaded onto the patient's android phone.</s><s xml:id="_pNqaPyR">Face-to-face training was provided by the researcher, and the tutorial was provided in the mobile application.</s><s xml:id="_u2eQrmY">Participants were asked to demonstrate the VDOT by taking and sending one video during this process.</s><s xml:id="_ryzRfbq">They were also asked to send and use the side effect reporting system.</s><s xml:id="_YkhvJcR">Participant could obtain technical support throughout the study from the researcher by email or phone.</s><s xml:id="_STCdzug">Supervisors need to learn how to complete the task of approving the VDOT and side effect reporting.</s><s xml:id="_H99WtdW">After the training session, the patient and supervisor need to use the mobile apps to complete the task of sending and approving VDOT as well as side effect reporting every day for 2 months.</s><s xml:id="_34ZPnYC">Before, at the 4-weeks and 8 weeks follow-up, participants completed the MyMAAT and IMI questionnaire.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qWyh73c">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NXZWRQR">Sociodemography</head><p xml:id="_qaYDQuK"><s xml:id="_t33DQzP">Eighty-two participants (patients) initially agreed to participate in the GRVOTS.</s><s xml:id="_BK9t738">Among them, 71 patients completed two months of trials.</s><s xml:id="_2vnRZG3">11 (13%) participants were lost to follow-up.</s><s xml:id="_N4X9Dtb">A total of 71 eligible participants were selected from 18 healthcare centers.</s><s xml:id="_kzzT4JA">The median age was 38 (interquartile range [IQR] 19-65) years, 64.9% (48/71) were male, and 90.4% (66/71) were Malaysian.</s><s xml:id="_JsGzGGD">Out of 71 participants, 90.1% (64) tested negative for HIV and showed BCG scars, while 62% <ref type="bibr" target="#b14">[15]</ref> were non-smokers.</s><s xml:id="_CAn364T">Most participants, comprising 71.6% (63 out of 71), are employed, and 60.6% (43 out of 71) of patients have a monthly income exceeding RM2160.</s><s xml:id="_KhYuYPF">This factor holds significance as non employed and lower income levels are associated with loss to follow up <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_tsqcNch">The descriptive table regarding the participants is shown in Table <ref type="table" target="#tab_1">1</ref> below.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_74CfTEv">Descriptive number of videos</head><p xml:id="_w7NC6b2"><s xml:id="_rHkvmqf">Approximately 7% of video clips submitted during the first two months of treatment were corrupted because of a software bug that was subsequently fixed.</s><s xml:id="_kd2F5s5">Despite the corruption, the patient kept the video clip in their gallery and utilized WhatsApp as an alternative platform to share it with their supervisor.</s><s xml:id="_etbDzAp">If the issue persists for more than three days, the patient will lose eligibility for GRVOTS, necessitating a shift to physical DOTS for ongoing treatment.</s><s xml:id="_temNSyf">However, similar occurrences are common in trial studies, as observed in various other research investigations <ref type="bibr" target="#b16">[17]</ref>.</s><s xml:id="_uDyJDmU">Thus, in our main analysis, we assumed that the submission of a corrupted clip represented pill ingestion since patients were unaware that their submitted videos were corrupted.</s><s xml:id="_KjsYsre">Table <ref type="table" target="#tab_2">2</ref> shows descriptive statistics of the study variables.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8nNZhwV">Treatment adherence</head><p xml:id="_U3HtSF3"><s xml:id="_KQNcEVk">As for the treatment adherence rate was calculated based on number of videos received over the total video expected.</s><s xml:id="_Sy4Xz2H">The t-test of the treatment adherence level indicates good treatment adherence of the participant of GRVOTS as a mobile application as shown in Table <ref type="table" target="#tab_3">3</ref>.</s></p><p xml:id="_9rYd59c"><s xml:id="_Kepfq9W">The results of this study can be categorized into four distinct outcomes: three outcomes pertain to the Intrinsic Motivation Questionnaire (IMI), specifically addressing Interest, Competence, and Choice, while the fourth outcome relates to the MyMAAT score.</s><s xml:id="_8C8aznm">The comparison of mean percentage scores for the three components of IMI and MyMAAT across three different time intervals yielded three separate sets of results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uV4PBvD">Intervention Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WxZfbAB">(i) Within-subject difference (time effect)</head><p xml:id="_wqqff2u"><s xml:id="_wcTNJEc">Overall, there is a significant increase in all scores of IMI and MyMAAT across three-time intervals after using the GRVOTS mobile apps as shown in Table <ref type="table" target="#tab_4">4</ref>.</s><s xml:id="_HwnptQ6">The participants' adherence score (MyMAAT) and motivation score (IMI) scores significantly increased over 3-time interval.</s><s xml:id="_SSTQxaZ">Therefore, the intervention is effective.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dqkUxzU">(ii) Within-subject contrast table</head><p xml:id="_4ETAVRX"><s xml:id="_4zmVdGM">Regarding the test within-subject contrast table as shown in Table <ref type="table" target="#tab_5">5</ref>, there was a significant increase in the MyMAAT and IMI score score from T1 to T2 and T0 to T2 with mean of 4.35 (1.78, 6.93) and 5.38 (2.67, 8.10) respectively.</s><s xml:id="_jZr29YH">However, it's important to highlight that there was no statistically significant increase observed in the MyMAAT score from T0 to T1 with mean of 1.03 (95% CI: 1.14,3.20).</s><s xml:id="_3yHds74">MyMAAT marks showed the lowest mean different from T0 to T2 only increase by <ref type="bibr" target="#b4">5</ref>.38 (95% CI: 2.67, 8.10: p &lt; 0.001).</s><s xml:id="_RsrutHB">Whereas the IMI Interest domain showing the highest mean difference by 19.76 (95% CI: 16.37, 21.152: p &lt; 0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KdwdRXD">(iii) Contrast (Post Hoc Comparison)</head><p xml:id="_qY4ZRbT"><s xml:id="_M32ymKz">Profile plot lines of intervention illustrate the improvement in the mean score of IMI and MyMAAT throughout the 3-time intervals (Figs. <ref type="figure">1</ref> and <ref type="figure">2</ref>).</s><s xml:id="_VFgW28G">The post hoc      value IMI (interest) p-value IMI(Competence) p-value IMI (Choice p-value T0-T1 mean difference (95%CI) 1.03 (1.14, 3.20) 0.746 5.75(2.64,</s><s xml:id="_ZKtb7F2">8.86) &lt; 0.001 2.80 (0.90, 4.71) 0.002 2.34 (0.40, 4.28) 0.013 T1-T2 mean difference.</s><s xml:id="_UhgSZQK">(95% CI) 4.35 (1.78, 6.93) &lt; 0.001 13.01(10.09,</s><s xml:id="_ZCTyMmV">15.94) &lt; 0.001 4.70 (2.77, 6.64) &lt; 0.001 6.16 (4.16, 8.15) &lt; 0.001 T0-T2 mean difference.</s><s xml:id="_hhQ4Wt3">(95% CI) 5.38 (2.67, 8.10) &lt; 0.001 18.76 (16.37, 21.15) &lt; 0.001 7.51 (5.69, 9.33) &lt; 0.001 8.49 (6.63, 10.4) &lt; 0.001 Repeated measure ANOVA (time-effect) (Ho: There is no change of MyMAAT and IMI in 3 repeated measurements) Fig. 1 Profile plot of estimated marginal means of MyMAAT (Left) and IMI (Interest) (Right)</s></p><p xml:id="_TykFppW"><s xml:id="_rUAuAaS">showing a gradual and increasingly positive effect initially and speed upafter one month of intervention.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Cgwtkdw">Discussion</head><p xml:id="_xy9EGH9"><s xml:id="_dgarews">Discovering an innovative approach to enhance TB medication adherence is of utmost importance, and implementing a mobile app-based VDOT system with gamification and real-time elements to foster motivation could potentially offer a viable solution.Gamification, defined as applying gaming principles to non-game activities to influence behavior with the potential to enhance engagement and encourage desired actions, such as task completion <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_6x24kXx">Mobile apps also hold promise in improving chronic disease self-management <ref type="bibr" target="#b21">[22]</ref>.</s></p><p xml:id="_5EBxsJ3"><s xml:id="_8Hh8sVd">In GRVOTS mobile apps, gamification is integrated to enhance user experience and sustainability <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_dB8pNRJ">This study aims to assess the GRVOTS mobile app's impact on patient treatment adherence and motivation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zwNpREk">Treatment adherence rate</head><p xml:id="_9V2tuvY"><s xml:id="_YZWaJaS">According to various guidelines, maintaining a high level of adherence at 80% or above over two weeks is a positive and statistically significant achievement <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_W2qAHaG">In this study, the average treatment adherence score was 90.87% (1.796), which was significantly higher than the standard treatment adherence score of 80% with a difference of 10.873 (95% CI 7.29, 14.46; p &lt; 0.001).</s><s xml:id="_hhfp9vH">The research findings align with previous studies that have supported the use of mobile phones to improve medication adherence among tuberculosis patients or users.</s><s xml:id="_hPrbnfP">Similar adherence levels have been reported throughout high and middle to low-income settings where VDOTS is utilized, including the United States countries <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_XQ9jFk8">Our adherence rate was higher than the median adherence rates reported in studies conducted in Vietnam, Kenya, Uganda, and the USA <ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_GtK996Z">Moreover, our study demonstrated a treatment adherence rate of 90.87% through GRVOTS, significantly surpassing the Malaysian TB treatment adherence rate of 81% recorded in 2017 via physical Directly Observed Therapy Short Course (DOTS) <ref type="bibr" target="#b31">[32]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5y4xdCN">Intervention effect of RM ANOVA in MyMAAT (medication adherence score)</head><p xml:id="_aABdnDs"><s xml:id="_PFb9tCP">This study found a significant improvement in the patient's medication adherence score (MyMAAT) with the GRVOTS mobile apps throughout the 3-time interval.</s><s xml:id="_E34yR7f">The time-intervention effect produces a significant difference in the mean percentage score of MyMAAT score time between pre-and 1 to 2 months post-usage of GRVOTS with significant positive liner trend indicating that GRVOTS positively impacts medication adherence, especially among working-age Tuberculosis patients consistently.</s></p><p xml:id="_WgkVspX"><s xml:id="_6hwXkfN">GRVOTS mobile apps have been found to enhance medication adherence, as supported by Wiecek et al. 's (2020) study, which demonstrated that using a digital therapeutic mobile app can maintain optimal adherence rates in adults with chronic conditions for an extended period <ref type="bibr" target="#b32">[33]</ref>.</s><s xml:id="_ayBENuH">In addition, Tran et al. 's (2022) scoping review also demonstrates that mobile apps incorporating gamification, reminders, incentives, education, and social community interventions positively impact long-term medication adherence, highlighting the significant promise of integrating mobile technology for effective management in practical settings <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_22HEAsR">The review highlights mobile technology's promise in enhancing real-world medication adherence, emphasizing its significant potential for effective management through integrated features like gamification, reminders, incentives, education, and social community interventions.</s></p><p xml:id="_Skq4cE2"><s xml:id="_X347vSV">As for the implication from the trend, after post-hoc analysis, it is shown to be linear in trend which means constant small increase in MyMAAT score over time.</s><s xml:id="_gdwvka3">It could be attributed to the habit of medication intake, which typically takes about 21 days or more to establish.</s><s xml:id="_y4BDpxy">Therefore, it might take more time to observe a significant difference in MyMAAT results compared to our 2-month intervention study <ref type="bibr" target="#b34">[35]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MXdXK3P">Intervention effect of RM ANOVA in IMI (Instrinsic Motivation score)</head><p xml:id="_tJTPgQ8"><s xml:id="_ruKRZ4J">This study found a significant improvement in patients with Tuberculosis disease motivation across subdomains of interest, competence, and choice after using the GRV-OTS mobile apps throughout the 3-time interval.</s><s xml:id="_FG3eEca">The time-intervention effect produces a significant difference in the mean percentage of IMI score of time between preand 1 to 2 months post-usage of GRVOTS, indicating that GRVOTS can increase patient motivation, especially among working-age tuberculosis patients.</s><s xml:id="_JsCQjAc">The findings align with many studies supporting that mobile phone apps can improve user motivation.In a study conducted by Jeno, Grytnes et al. ( <ref type="formula">2017</ref>), the relationship between achievement scores, perceived competence, and intrinsic motivation in mobile app learning (specifically Art-sApp) was examined and compared to traditional book learning.</s><s xml:id="_uQtr29r">The findings revealed a significant association between ArtsApp mobile app usage and achievement, with intrinsic motivation mediating this relationship <ref type="bibr" target="#b35">[36]</ref>.</s></p><p xml:id="_KPRsUBk"><s xml:id="_NAgnsgU">Mobile apps containing gamification features for medication adherence have shown promising results in improving medication adherence via motivation among users.</s><s xml:id="_5gxGRAV">According to one scoping review regarding "The Use of Gamification and Incentives in Mobile Health Apps to Improve Medication Adherence", it was found that gamification features in mobile applications, such as dosage reminders, incentives, education, and social community interventions in mobile apps, can contribute to maintaining optimal medication adherence over time <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_kHgKnfs">Furthermore, game elements and app features such as rewards can be used as tools to support basic psychological needs that align with the self-determination theory of Desi and Ryan for behavior change in various health areas such as medication adherence <ref type="bibr" target="#b36">[37]</ref>.</s><s xml:id="_h3D2BzT">Overall, gamification features in mobile applications can improve medication adherence among users by fostering motivation and resilience and incentivizing the user's need to fight their illnesses.</s></p><p xml:id="_Ztjz2Gs"><s xml:id="_uenvefn">As for the implication from the trend, out of the three motivation components measured, the subdomains of interest and choice showed significant quadratic trend increases across the three-time intervals.</s><s xml:id="_szeWAxx">The increment indicates that the intervention had a gradual and increasingly beneficial effect on IMI scores, with the most significant changes occurring at T1 to T2 after the first month of mobile app usage.</s><s xml:id="_WpV2nrk">In other words, the gamification component in mobile apps was much appreciated and effective after a specific duration of usage, which was one month.</s></p><p xml:id="_KydJZbx"><s xml:id="_CeByNKb">There are a few reasons for the drastic increment: first: in our gamified mobile apps, the progression mechanism, such as the progress meter, performance progress, color change calendar, and badge reward, unlocked and advanced significantly only after using the app for a month.</s><s xml:id="_FzYNPCR">Therefore, after a month, only patients would feel most of the app's satisfaction effect, and this intrinsic motivation subdomain will improve user engagement and motivation <ref type="bibr" target="#b37">[38]</ref>.</s></p><p xml:id="_TQSffjf"><s xml:id="_HQ3Xaxn">Secondly, different users have different learning styles; some may take up to 3 months to become familiar with certain mobile apps.</s><s xml:id="_sQf5M4y">Users may need time to become familiar with the app's gamification features, understand the available choices and options, and learn how their choices impact their experience.</s><s xml:id="_tQjF9kJ">As they become more experienced and knowledgeable about the app's gamified elements, they may feel more confident in making choices that align with their interests and preferences, subsequently increasing the interest and choice component <ref type="bibr" target="#b38">[39]</ref>.</s></p><p xml:id="_M259JP3"><s xml:id="_DHSf3ch">Thirdly, app developers often iterate and improve their gamification systems based on user feedback and data analysis.</s><s xml:id="_EU6E4Yp">After a month of usage, users may notice refinements and updates that enhance the interest and choice component.</s><s xml:id="_H7Hs33Y">Our study asked some patients to update their mobile app version to cater to a smoother VDOT feature.</s><s xml:id="_mCqcfF3">These improved apps provide more tailored recommendations based on user preferences and behaviors, increasing users' ability to make choices aligned with their interests.</s><s xml:id="_dvZv5nC">As users become more familiar with the app, progress in their gameplay, personalize their experience, engage socially, and receive feedback and improvements, mobile app gamification's interest and choice component is likely to increase significazntly.</s><s xml:id="_xFebdTN">It can result in a more engaging and motivating user experience over time <ref type="bibr" target="#b36">[37]</ref>.</s></p><p xml:id="_GfcrdNw"><s xml:id="_PJG8jHe">Out of all three subdomains, only competence showed a linear but not quadratic trend, which means that throughout the intervention, the motivation level of competence gradually and constantly increased.</s><s xml:id="_qCwatqc">The competence component of mobile app gamification can constantly and gradually increase after intervention via several components of competency which are skills and gamification elements implemented.</s></p><p xml:id="_9PbqbEN"><s xml:id="_hdkATzw">Users can improve their skills by engaging with the app's gamified features.</s><s xml:id="_kNtVwx3">As they become more familiar with the app and gain experience, their perceived competence gradually increases <ref type="bibr" target="#b39">[40]</ref>.</s><s xml:id="_ZueWH8P">This skill improvement happens through encountering various challenges and tasks within the app's gamified environment.</s><s xml:id="_CE2ZmdE">By actively participating and successfully completing these tasks, users gain a sense of accomplishment and reinforce their belief in their own competence.</s><s xml:id="_MUga6tV">The app's design is important for enhancing users' skills, including clear progression, goals, and feedback.</s><s xml:id="_XSq3Gfk">Tutorials, exercises, and resources can also support users in acquiring new competencies.</s><s xml:id="_6vXHrWA">As users witness their progress, their confidence grows, motivating them to continue using the app and improving their skills.</s><s xml:id="_ZDekY5U">Active engagement and practice contribute to skill improvement and sustained engagement with the app's gamified features <ref type="bibr" target="#b37">[38]</ref>.</s></p><p xml:id="_KWczS3q"><s xml:id="_J9WmHHP">Gamification in mobile apps has been found to enhance users' competence domain in intrinsic motivation.</s><s xml:id="_B46pE27">The design and user experience of gamified apps play a crucial role in this increase.</s><s xml:id="_C4Dh62R">Immersion-related elements in app design fulfill users' needs for competence, autonomy, and relatedness, thereby boosting intrinsic motivation.</s><s xml:id="_d5M5Wq9">Effective gamification interventions provide a sense of progression and challenging tasks, motivating users to enhance their skills and overcome new challenges.</s><s xml:id="_JFWDRxf">Timely and meaningful rewards, along with feedback and recognition, validate users' growing abilities and contribute to increased competence <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_CVGhRdN">Goal-setting mechanisms allow users to set specific targets and break them down into achievable tasks, fostering a sense of mastery.</s><s xml:id="_PKU5HRm">As users achieve their goals, their perceived competence improves, further enhancing the competence component.</s><s xml:id="_abspH8B">As whole, gamified mobile app interventions that incorporate skill development, clear progression, feedback and recognition, goal setting, and social comparison can lead to a gradual and consistent increase in the competence component.</s><s xml:id="_ff4THX8">This, in turn, drives users' motivation, engagement, and overall skill improvement <ref type="bibr" target="#b41">[42]</ref>.</s></p><p xml:id="_FegCAPM"><s xml:id="_3xEct5j">Out of all three components of intrinsic motivation, the interest component has the highest mean difference marks of T0 and T2 by 18.76, followed by choice and competence.</s><s xml:id="_EmaEMDT">The highest mean difference is due to the interest component being the most significant component of the intrinsic motivation inventory <ref type="bibr" target="#b42">[43]</ref>.</s><s xml:id="_8DZCa4q">When individuals are interested in an activity, they are more likely to engage in it willingly and persistently, even in the face of challenges.</s><s xml:id="_FNVbvhA">Interest can also enhance individuals' perceived competence, which in turn can further reinforce their intrinsic motivation <ref type="bibr" target="#b41">[42]</ref>.</s></p><p xml:id="_cVFcH2S"><s xml:id="_zvUvze6">The significance of this finding is twofold.</s><s xml:id="_JZsVZeu">First, it highlights the importance of fostering interest in promoting intrinsic motivation.</s><s xml:id="_VkDkxM8">You can enhance their motivation and engagement levels by designing activities, tasks, or learning experiences that tap into individuals' interests and passions <ref type="bibr" target="#b43">[44]</ref>.</s></p><p xml:id="_2cs82ak"><s xml:id="_fG7emzM">Second, the significance of the interest component within the intrinsic motivation inventory reinforces its role as a primary driver of individuals' motivation.</s><s xml:id="_ge8St2T">Recognizing the impact of interest can help researchers, educators, and practitioners better understand and support intrinsic motivation in various domains, such as education, work, or personal hobbies <ref type="bibr" target="#b14">[15]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_e7FpmEZ">Limitations and strenght</head><p xml:id="_CUaR6Ws"><s xml:id="_Uc9BCMB">The single-arm intervention study's design may present difficulties in evaluating treatment effectiveness.</s><s xml:id="_GtvwTVj">Moreover, it's important to note that the study's results may have limited applicability to all Malaysian TB patients due to the exclusive focus on government facilities.</s><s xml:id="_RMFyTtB">This study stands out as high-quality due to its strong methodological design.</s><s xml:id="_jbRdDvd">Unlike many mobile apps, which often lack a solid theoretical foundation, our research included a validation study to confirm the intended elements in the apps.</s><s xml:id="_sy5jRBr">Furthermore, while most studies only focus on treatment adherence, this study also investigates the apps' capacity to enhance patient motivation <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_hapzJPP">In addition, this study utilized validated tools tailored to the target population, achieved a follow-up rate exceeding 80%, and administered intervention packages under the supervision of medical professionals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Hak7xTa">Suggested improvement</head><p xml:id="_ePWMVf3"><s xml:id="_a5fxKj9">A community-based trial will be performed to measur the effectiveness of the mobile app intervention toward motivation.</s><s xml:id="_jkpREvc">A better study design of multiple-arm studies should be performed, as we can compare multiple interventions or doses of the same intervention to a control group to better evaluate the effectiveness of VDOTs against the current standard of care or alternative technologies in resource-limited, high-disease-burden settings.</s><s xml:id="_AAhm7Ge">This approach allows for comparing outcomes between the two groups, reducing the risk of bias, and increasing the validity of the results.</s></p><p xml:id="_kMshRfX"><s xml:id="_zC3jFwT">In the future, to ensure that this intervention is effective, selecting an appropriate candidate for VDOTS intervention is essential.</s><s xml:id="_Dz8gewp">This is because patient completion rates highly depend on their views about the treatment's effectiveness and the ailment itself.</s><s xml:id="_Zze2cKv">Research shows a unique link between the belief in the significance of adherence to treatment and the completion rates of TB treatment.</s><s xml:id="_hF52FxH">People who dropped out of the program were less likely to believe in the treatment, and patients' apprehension about the reduced efficacy of treatment acted as a driving force for them to adhere to the treatment schedule <ref type="bibr" target="#b45">[46]</ref>.</s><s xml:id="_v7U5SJb">Thus, promoting a better understanding of the disease and treatments through health education may be beneficial in raising completion rates <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b46">47]</ref>.</s></p><p xml:id="_36xx6uj"><s xml:id="_gC6yED9">Future studies addressing cost and cost-effectiveness are also needed.</s><s xml:id="_MZubeSV">In addition, in other settings, such as the United States, VDOTS has successfully been coupled with individualized case management to allow real-time intervention after missed doses; the role of this approach in our setting is unknown and should be explored <ref type="bibr" target="#b47">[48]</ref>.</s></p><p xml:id="_mCabxVH"><s xml:id="_TjU2mcW">Our study's results reveal a quadratic trend, showing a notable surge in the metric after the first month, followed by stabilization.</s><s xml:id="_JTEv2z5">We suggest extending the study for a 6-month period to gain deeper insights into the motivation pattern.</s><s xml:id="_t8RHSPa">Furthermore, we propose supplementing the trend analysis with a stratified analysis to examine motivation variations among different sociodemographic groups.</s><s xml:id="_ZP2nfwf">This approach, considering variables such as age and gender, would enhance the comprehensiveness of the study, as outcomes might diverge based on these factors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YUfEFsc">Conclusion</head><p xml:id="_ry84ZHa"><s xml:id="_HBP8CRR">The GRVOTS mobile app demonstrates effectiveness in not only enhancing treatment adherence with a significantly higher score of 90.87% compared to the standard 80%, but also in elevating patient motivation across three time intervals.</s><s xml:id="_HG3nn4e">In summary, GRVOTS, a theory-based mobile application integrating real-time gamification, stands as a promising innovation for boosting medication adherence and motivation among TB patients.</s><s xml:id="_9TugJku">By linking patients, supervisors, and TB administrators, this app offers a potential solution for enhancing the efficiency of TB management systems, including swift defaulter tracing.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_dbZ7MYm"><s xml:id="_ypdkq9h">comparison of MyMAAT and IMI (Competence) shows a linear trend by (F (1,70) = 23.63,</s><s xml:id="_zZZz9Ek">p &lt; 0.01, partial eta = 0.252 (&gt; 0.15), power = 0.998 and by (F (1,70) = 102.306),</s><s xml:id="_5yfENX3">p &lt; 0.01, partial eta = 0.594 (&gt; 0.15), power = 100 (&gt; 100%) implying that there is a consistent increase in the response variable (MyMAAT score and IMI (Competences) score) across the three time periods.</s><s xml:id="_P23Yxek">Whereas the post hoc comparison of IMI (Interest) and IMI (Choice) showed quadratic trend by F (1,70 = 10.34),</s><s xml:id="_3SqyyCH">p = 0.002, partial eta 0.129 = (&gt; 0.15), power = 0.887 (&gt; 100%) and by F(1,70) = 7.333, p = 0.009, partial eta 0.095 (&gt; 0.15), power = 0.761).</s><s xml:id="_rJ4uKBr">The quadratic trend scores demonstrate a significant non-linear pattern over time.</s><s xml:id="_QsbBSYW">Assuming a positive quadratic trend (concave up), the intervention initially led to a slow change in scores, followed by acceleration, a peak between measurement points, and eventual leveling off or a slight decrease.</s><s xml:id="_tQfe8wW">Overall, the intervention had a meaningful impact on participants' IMI (Interest) and IMI (Choice) scores,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 Fig. 1</head><label>21</label><figDesc><div><p xml:id="_dv6vJdg"><s xml:id="_GrGGBck">Fig. 2 Profile plot of estimated marginal means of My IMI (Competence) (Left) and IMI (Choice) (Right)</s></p></div></figDesc><graphic coords="5,56.69,404.37,481.92,178.80" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_NekxkXp"><s xml:id="_rbyna76">Descriptive Table Sociodemographic of the participant n = 71</s></p></div></figDesc><table><row><cell>Variable</cell><cell>Median (Range)</cell><cell>Frequency%(N)</cell></row><row><cell>Sociodemographic</cell><cell></cell><cell></cell></row><row><cell>Gender</cell><cell></cell><cell>64.9 (48)</cell></row><row><cell>Male</cell><cell></cell><cell>31.1 (23)</cell></row><row><cell>Female</cell><cell></cell><cell></cell></row><row><cell>Nationality</cell><cell></cell><cell>90.4(66)</cell></row><row><cell>Malaysia</cell><cell></cell><cell>6.8 (5)</cell></row><row><cell>Non-Malaysian</cell><cell></cell><cell></cell></row><row><cell>Occupation</cell><cell></cell><cell>24 (17)</cell></row><row><cell>Non employment</cell><cell></cell><cell>76 (54)</cell></row><row><cell>Employment</cell><cell></cell><cell></cell></row><row><cell>Education level</cell><cell></cell><cell>7 (5)</cell></row><row><cell>No education</cell><cell></cell><cell>2.8 (2)</cell></row><row><cell>Primary</cell><cell></cell><cell>69 (49)</cell></row><row><cell>Secondary</cell><cell></cell><cell>21.1 (15)</cell></row><row><cell>Higher</cell><cell></cell><cell></cell></row><row><cell>Household income</cell><cell></cell><cell>39.4 (28)</cell></row><row><cell>&lt; 2160</cell><cell></cell><cell>60.6 (43)</cell></row><row><cell>&gt; 2160</cell><cell></cell><cell></cell></row><row><cell>TB Profile</cell><cell></cell><cell></cell></row><row><cell>HIV status</cell><cell></cell><cell>1.4 (1)</cell></row><row><cell>HIV Positive</cell><cell></cell><cell>90.1 (64)</cell></row><row><cell>HIV Negative</cell><cell></cell><cell>8.5 (6)</cell></row><row><cell>Unknown</cell><cell></cell><cell></cell></row><row><cell>BCG scar</cell><cell></cell><cell>9.9 (7)</cell></row><row><cell>Absent</cell><cell></cell><cell>90.1 (64)</cell></row><row><cell>Present</cell><cell></cell><cell></cell></row><row><cell>Smoking Status</cell><cell>2500(500-7000)</cell><cell>62 (44)</cell></row><row><cell>Non-Smoking</cell><cell>2398.61(1270.585)</cell><cell>38 (27)</cell></row><row><cell>Smoking</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_qEgkqBP"><s xml:id="_kNSCGHW">Descriptive table on overall video received or not received n = 71</s></p></div></figDesc><table><row><cell>Variable</cell><cell>(Med/Mean)</cell></row><row><cell>Video received</cell><cell>3871</cell></row><row><cell>Video not received -failed to be sent</cell><cell>301</cell></row><row><cell>Video with technical issue-cannot be viewed</cell><cell>545</cell></row><row><cell>Total video expected</cell><cell>4260</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p xml:id="_5hGumdG"><s xml:id="_hrhWf7p">The one-sample t-test of the treatment adherence rate of all participants</s></p></div></figDesc><table><row><cell></cell><cell>N</cell><cell>Mean (SE) Mean paired</cell><cell>Ta</cell><cell>p-</cell></row><row><cell></cell><cell></cell><cell>difference</cell><cell>(df)</cell><cell>value</cell></row><row><cell></cell><cell></cell><cell>(95% CI)</cell><cell></cell></row><row><cell>Treatment</cell><cell cols="2">71 90.87(1.80) 10.87</cell><cell cols="2">6.07(70) &lt; 0.001</cell></row><row><cell>adherence</cell><cell></cell><cell>(7.29,14.46)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc><div><p xml:id="_sqfShep"><s xml:id="_ztn6DMT">Effect of GRVOTS mobile apps usage on 3 component of IMI marks and MyMAAT Marks</s></p></div></figDesc><table><row><cell>Outcome</cell><cell cols="4">Baseline (Mean +-SD) 1st month (Mean +-SD) 2nd month (Mean +-SD) F-stat (df)</cell><cell cols="2">Partial eta square p-value</cell></row><row><cell>MyMaat</cell><cell>49.68(6.05)</cell><cell>50.70(5.83)</cell><cell>55.06(6.17)</cell><cell>15.74 (1,70)</cell><cell>0.184</cell><cell>&lt; 0.001</cell></row><row><cell>IMI (Interest)</cell><cell>21.48(5.342)</cell><cell>27.48(8.634)</cell><cell>40.14(6.72)</cell><cell>139.29 (1,70)</cell><cell>0.666</cell><cell>&lt; 0.001</cell></row><row><cell cols="2">IMI (Competence) 20.28(4.32)</cell><cell>23.08(4.86)</cell><cell>27.79(4.79)</cell><cell>48.52(2,140)</cell><cell>0.409</cell><cell>&lt; 0.001</cell></row><row><cell>IMI (Choice)</cell><cell>15.38(3.47)</cell><cell>17.72(5.15)</cell><cell>23.87(5.98)</cell><cell cols="2">62.00(1366.51,140) 0.470</cell><cell>&lt; 0.001</cell></row></table><note xml:id="_98gaSG7"><p>Repeated measure ANOVA (time-effect)</p><p><s xml:id="_vynhtUj">(Ho: There is no change of MyMAAT and IMI in 3 repeated measurements)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 5</head><label>5</label><figDesc><div><p xml:id="_dwECqNj"><s xml:id="_ZWejxsD">Post Hoc Comparison of marks for each pair of time levels</s></p></div></figDesc><table><row><cell>Outcome</cell><cell>MyMaat</cell><cell>p-</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_PBWjHWn">Acknowledgements</head><p xml:id="_jV75eaQ"><s xml:id="_gXqn36E">The author would like to thank to the <rs type="institution">Director General of Health Malaysia</rs> for his permission to publish this study.</s><s xml:id="_RARDYBe">We give many thanks also to the <rs type="institution">Universiti Teknologi MARA</rs>.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_8zHeehX">Funding</head><p xml:id="_xrzFMCV"><s xml:id="_STDWQKu">This study is funded by the <rs type="funder">Joint TDR/World Health Organization Western Pacific Region Small Grant Scheme for Implementation Research</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_u3bREBR">Data availability</head><p xml:id="_28YQWC9"><s xml:id="_D27Tnhj">All data supporting the study findings are within the manuscript.</s><s xml:id="_bN78qGb">Additional details information and raw data are available from the corresponding author on reasonable request.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Efv8E3N">Author contributions</head><p xml:id="_XSduvcW"><s xml:id="_Fw6EHNP">SAA and NI conceived the project.</s><s xml:id="_ntMtnE6">SAA contributed to data collection.</s><s xml:id="_VAubeqj">SAA, NI, and YZ contributed to data analysis.</s><s xml:id="_pE65thV">SAA, NI, and II contributed to mapping the apps architecture.</s><s xml:id="_wc6Zgv6">NI supervised the study.</s><s xml:id="_3XEWJEM">The manuscript was written mainly by SAA with the approval of all authors.</s><s xml:id="_4KdDTvr">All authors read and approved the final version of manuscript for publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_b2hUjvg">Declarations Ethic approval and consent to participate</head><p xml:id="_3j7aKCV"><s xml:id="_pWADp4Y">The study was approved by the Malaysia Ministry of Health Medical Research Ethics Committee (reference number NMRR-21-1016-58994(IIR)) and the Research Ethics Committee (REC/07/2021), Universiti Teknologi MARA (UiTM).</s><s xml:id="_pbNZWj8">All methods in this study were performed according to the ICH Good Clinical Practice Guidelines, Malaysia Good Clinical Practice Guidelines, and the Declaration of Helsinki.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_G54ebsS">Consent for publication</head><p xml:id="_n5dVqfs"><s xml:id="_PaP7aF6">Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HXdUSSw">Competing interests</head><p xml:id="_w32qGhU"><s xml:id="_wpmVejU">The authors declare no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kjbF3xm">Publisher's note</head><p xml:id="_VH4F3F2"><s xml:id="_KqxMgtU">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><surname>Who</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SdFc4FM">GLOBAL TUBERCULOSIS REPORT</title>
		<imprint>
			<date type="published" when="2020">2020. 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO. GLOBAL TUBERCULOSIS REPORT 2020. 2020.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<author>
			<persName><forename type="first">N</forename><surname>Ismail</surname></persName>
		</author>
		<idno type="DOI">10.54561/prj1701109s</idno>
		<title level="m" xml:id="_VpNxJta">Mathematical modelling of Tuberculosis transmission and impact of isoniazid preventive therapy in Malaysia</title>
		<imprint>
			<publisher>University of Malaya</publisher>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>Nurhuda Ismail</note>
	<note type="raw_reference">Ismail N. Mathematical modelling of Tuberculosis transmission and impact of isoniazid preventive therapy in Malaysia. /Nurhuda Ismail: University of Malaya; 2017.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_gZHdea9">Determinants of unsuccessful treatment outcomes and mortality among Tuberculosis patients in Malaysia: a registry-based cohort study</title>
		<author>
			<persName><forename type="first">Psk</forename><surname>Tok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Liew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Razali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Loganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chinna</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0231986</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ze2mhM7">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">231986</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tok PSK, Liew SM, Wong LP, Razali A, Loganathan T, Chinna K, et al. Determinants of unsuccessful treatment outcomes and mortality among Tuberculosis patients in Malaysia: a registry-based cohort study. PLoS ONE. 2020;15(4):e0231986.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main" xml:id="_CYhfusM">Identifying and Validating Requirements of a Mobile-Based Self-Management System for People Living ith HIV</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mehraeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Reza</forename><surname>Safdari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sas</forename><surname>Alinaghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Zahed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arji</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehraeen E, Reza Safdari, Alinaghi SAS, Zahed NM, Arji G. Identifying and Validating Requirements of a Mobile-Based Self-Management System for People Living ith HIV. 2018.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_xHYnmrR">Identifying features of a mobile-based application for self-care of people living with T2DM</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mehraeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Noori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Nazeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heydari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mehranfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Moghaddam</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2020.108544</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nTdCpBW">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehraeen E, Noori T, Nazeri Z, Heydari M, Mehranfar A, Moghaddam HR et al. Identifying features of a mobile-based application for self-care of people living with T2DM. Diabetes Res Clin Pract. 2021;171.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_A9Uky6d">A mobile-based self-management application-usability evaluation from the perspective of HIV-positive people</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mehraeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Safdari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seyedalinaghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Noori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kahouei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Soltani-Kermanshahi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WcKrpjq">Health Policy and Technology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="294" to="301" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehraeen E, Safdari R, SeyedAlinaghi S, Noori T, Kahouei M, Soltani-Kerman- shahi M. A mobile-based self-management application-usability evaluation from the perspective of HIV-positive people. Health Policy and Technology. 2020;9(3):294-301.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main" xml:id="_2J8WGuy">Handbook for the use of Digital technologies to Support Tuberculosis Medication Adherence</title>
		<author>
			<persName><surname>Who</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO. Handbook for the use of Digital technologies to Support Tuberculosis Medication Adherence. 2017.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main" xml:id="_TJt6Uyq">The Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review</title>
		<author>
			<persName><forename type="first">Yejin</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcr</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Antoine</forename><surname>Flahault</surname></persName>
		</author>
		<idno type="DOI">10.2196/preprints.15727</idno>
		<imprint>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yejin Lee MCR, Antoine Flahault. The Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review. 2019.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main" xml:id="_6qpCK4M">Call for Increased Patient Support Focus-Review and Evaluation</title>
		<author>
			<persName><forename type="first">Sarah</forename><surname>Iribarren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Phda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rebecca</forename><surname>Schnall</surname></persName>
		</author>
		<author>
			<persName><surname>Rn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phda</forename><surname>Mph</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sarah Iribarren R, PhDa, Rebecca Schnall, RN, MPH, PhDa. Call for Increased Patient Support Focus-Review and Evaluation. 2016.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_NhAyv82">Gamification of Medication Adherence in Epilepsy</title>
		<author>
			<persName><forename type="first">Abdul</forename><surname>Rahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zXVfC98">Seizure</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="11" to="14" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abdul Rahim MI, Thomas RH. Gamification of Medication Adherence in Epilepsy. Seizure.2017;52:11-4.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_ZNZ6mES">The effect of gamification on motivation and engagement</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Alsawaier</surname></persName>
		</author>
		<idno type="DOI">10.1108/ijilt-02-2017-0009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h4TZzBv">The International Journal of Information and Learning Technology</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="79" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alsawaier RS. The effect of gamification on motivation and engage- ment. The International Journal of Information and Learning Technology. 2018;35(1):56-79.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_aaFYvS6">Gamification as a moderator for the impact of intrinsic motivation: Findings from a multigroup field experiment</title>
		<author>
			<persName><forename type="first">H</forename><surname>Treiblmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-M</forename><surname>Putz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lmot.2020.101655</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8kk7Pnt">Learning and Motivation</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Treiblmaier H, Putz L-M. Gamification as a moderator for the impact of intrin- sic motivation: Findings from a multigroup field experiment. Learning and Motivation.2020;71.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_4PRedAa">A Gamified Real-time Video Observed Therapies (GRVOTS) Mobile App via the Modified Nominal Group Technique: Development and Validation Study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Abas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zakaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mat</forename><surname>Zain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Yasin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KCsd4jJ">JMIR Serious Games</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">43047</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abas SA, Ismail N, Zakaria Y, Ismail I, Mat Zain NH, Yasin SM, et al. A Gamified Real-time Video Observed Therapies (GRVOTS) Mobile App via the Modified Nominal Group Technique: Development and Validation Study. JMIR Serious Games. 2023;11:e43047.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_xwrMUF5">Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm,Prospective Feasibility Study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Atre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sahasrabudhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ambike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jagtap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sayyad</surname></persName>
		</author>
		<idno type="DOI">10.2196/13411</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BnMfHn8">JMIR Form Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e13411</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Holzman SB, Atre S, Sahasrabudhe T, Ambike S, Jagtap D, Sayyad Y, et al. Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm,Prospective Feasibility Study. JMIR Form Res. 2019;3(3):e13411.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_fgaKMKd">Defining and Measuring Students&apos; Interest in Biology: An Analysis of the Biology Education Literature</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Rowland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Knekta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Corwin</surname></persName>
		</author>
		<idno type="DOI">10.1187/cbe.19-02-0037</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XsbBzEK">CBE Life Sci Educ</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rowland AA, Knekta E, Eddy S, Corwin LA. Defining and Measuring Students&apos; Interest in Biology: An Analysis of the Biology Education Literature. CBE Life Sci Educ. 2019;18(3):ar34.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_zxYTC5d">Characteristics and determinants of loss to follow-up among tuberculosis (TB) patients who smoke in an industrial state of Malaysia: a registry-based study of the years 2013-2017</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Z</forename><surname>Sharani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Yasin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zakaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Razali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nar</forename><surname>Demong</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12889-022-13020-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YSdqAZ6">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">638</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sharani ZZ, Ismail N, Yasin SM, Zakaria Y, Razali A, Demong NAR, et al. Char- acteristics and determinants of loss to follow-up among tuberculosis (TB) patients who smoke in an industrial state of Malaysia: a registry-based study of the years 2013-2017. BMC Public Health. 2022;22(1):638.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_cDe3KY4">Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre,analyst-blinded, randomised, controlled superiority trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Story</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Aldridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Garber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ferenando</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F73yQfV">Lancet</title>
		<imprint>
			<biblScope unit="volume">393</biblScope>
			<biblScope unit="issue">10177</biblScope>
			<biblScope unit="page" from="1216" to="1224" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G, et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre,analyst-blinded, randomised, controlled superior- ity trial. Lancet. 2019;393(10177):1216-24.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_KPBhpZg">How gamification motivates visits and engagement for online academic dissemination-An empirical study</title>
		<author>
			<persName><forename type="first">M-S</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T-Y</forename><surname>Chuang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chb.2015.08.025</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ydruVke">Computers in Human Behavior</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="16" to="27" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kuo M-S, Chuang T-Y. How gamification motivates visits and engagement for online academic dissemination-An empirical study. Computers in Human Behavior. 2016;55:16-27.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main" xml:id="_y8xCY7e">Defining Gamification -A Service Marketing Perspective</title>
		<author>
			<persName><forename type="first">Kai</forename><surname>Huotari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename></persName>
		</author>
		<idno type="DOI">10.1145/2393132.2393137</idno>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kai Huotari JH. Defining Gamification -A Service Marketing Perspective. 2012.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_XA7EXG8">Demographic differences in perceived benefits from gamification</title>
		<author>
			<persName><forename type="first">J</forename><surname>Koivisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hamari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mwUbDn3">Computers in Human Behavior</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="179" to="188" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koivisto J, Hamari J. Demographic differences in perceived benefits from gamification.Computers in Human Behavior. 2014;35:179-88.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main" xml:id="_cwZG6Qz">Gamification towards Sustainable Mobile Application</title>
		<author>
			<persName><forename type="first">Foong</forename><surname>Li Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zmk</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Chun</forename><forename type="middle">Kiat</forename><surname>Gan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foong Li Law ZMK, Chun Kiat Gan. Gamification towards Sustainable Mobile Application.2011.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_ez8W7py">Usability of Commercially Available Mobile Applications for Diverse Patients</title>
		<author>
			<persName><forename type="first">U</forename><surname>Sarkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Gourley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Lyles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Clarity</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Newmark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yKjJVHQ">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1417" to="1426" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sarkar U, Gourley GI, Lyles CR, Tieu L, Clarity C, Newmark L, et al. Usability of Commercially Available Mobile Applications for Diverse Patients. J Gen Intern Med.2016;31(12):1417-26.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_v9va5Nh">Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Nahid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Dorman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Alipanah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Brozek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cattamanchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HYqTTpF">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="147" to="e95" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Preven- tion/Infectious Diseases Society of America Clinical Practice Guidelines: Treat- ment of Drug-Susceptible Tuberculosis.Clin Infect Dis. 2016;63(7):e147-e95.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_gNnTrfT">Videoobserved therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ravenscroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kettle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Persian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ruda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Severin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Doltu</surname></persName>
		</author>
		<idno type="DOI">10.1183/13993003.00493-2020</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wESbrk5">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ravenscroft L, Kettle S, Persian R, Ruda S, Severin L, Doltu S, et al. Video- observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova. Eur Respir J. 2020;56(2).</note>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main" xml:id="_wbfBnmk">The Application of Telemedicine Technology to a Directly Observed Therapy Program for Tuberculosis: A Pilot Project</title>
		<author>
			<persName><forename type="first">James</forename><surname>Demaio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Peggy</forename><surname>Cooley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alan</forename><surname>Tice</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">James DeMaio LS, Peggy Cooley,Alan Tice. The Application of Telemedicine Technology to a Directly Observed Therapy Program for Tuberculosis: A Pilot Project. 2014.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_Y9KkCWR">Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcginnis</forename><surname>Pilote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Haque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Burzynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Macaraig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.2196/jmir.9825</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tVvW8nH">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">287</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lam CK, McGinnis Pilote K, Haque A, Burzynski J, Chuck C, Macaraig M. Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implemen- tation Study. J Med Internet Res. 2018;20(11):e287.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_fpvJC6Y">Enhancing management of tuberculosis treatment with video directly observed therapy in New York City</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Macaraig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burzynski</surname></persName>
		</author>
		<idno type="DOI">10.5588/ijtld.15.0738</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gTrHJS3">Int J Tuberc Lung Dis</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="588" to="593" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chuck C, Robinson E, Macaraig M, Alexander M, Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City. Int J Tuberc Lung Dis. 2016;20(5):588-93.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_GHV6gRU">Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California,USA</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Garfein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cuevas-Mota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Catanzaro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mhe84jX">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1806" to="1815" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garfein RS, Liu L, Cuevas-Mota J, Collins K, Munoz F, Catanzaro DG, et al. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California,USA. Emerg Infect Dis. 2018;24(10):1806-15.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_bC9CZfr">Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Suleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sundsmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vago</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2010.02.018</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kqcAjsg">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="80" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hoffman JA, Cunningham JR, Suleh AJ, Sundsmo A, Dekker D, Vago F, et al. Mobile direct observation treatment for tuberculosis patients: a techni- cal feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med. 2010;39(1):78-80.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_bm4f7BM">Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam:A prospective cohort study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Nguyen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijid.2017.09.029</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sezzq3A">Int J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="85" to="89" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nguyen TA, Pham MT, Nguyen TL, Nguyen VN, Pham DC, Nguyen BH, et al. Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam:A prospective cohort study. Int J Infect Dis. 2017;65:85-9.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_UJtSaZr">Stakeholders&apos; Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Sekandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kasiita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Onuoha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zalwango</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nakkonde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kaawa-Mafigiri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uAus2Nu">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">27131</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sekandi JN, Kasiita V, Onuoha NA, Zalwango S, Nakkonde D, Kaawa-Mafigiri D, et al. Stakeholders&apos; Perceptions of Benefits of and Barriers to Using Video- Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study. JMIR Mhealth Uhealth. 2021;9(10):e27131.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<author>
			<persName><surname>Moh</surname></persName>
		</author>
		<idno type="DOI">10.29171/azu_acku_pamphlet_ug490_n385_2016</idno>
		<title level="m" xml:id="_eyeEHbS">The National Strategic Plan for TB Control</title>
		<imprint>
			<date type="published" when="2016">2016-2020. 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">MOH. The National Strategic Plan for TB Control (2016-2020). 2016.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_yeBZqCd">Impact of a Multicomponent Digital Therapeutic Mobile App on Medication Adherence in Patients with Chronic Conditions: Retrospective Analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Wiecek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torres-Robles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Benrimoj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Garcia-Cardenas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pFwmGu7">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">17834</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wiecek E, Torres-Robles A, Cutler RL, Benrimoj SI, Garcia-Cardenas V. Impact of a Multicomponent Digital Therapeutic Mobile App on Medication Adherence in Patients with Chronic Conditions: Retrospective Analysis. J Med Internet Res. 2020;22(8):e17834.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_G2W95c8">The Use of Gamification and Incentives in Mobile Health Apps to Improve Medication Adherence: Scoping Review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>El-Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t4MPa9s">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">30671</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tran S, Smith L, El-Den S, Carter S. The Use of Gamification and Incentives in Mobile Health Apps to Improve Medication Adherence: Scoping Review. JMIR Mhealth Uhealth.2022;10(2):e30671.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_UZjEGyR">Habit Strength, Medication Adherence, and Habit-Based Mobile Health Interventions Across Chronic Medical Conditions: Systematic Review</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Badawy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Beg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Heneghan</surname></persName>
		</author>
		<idno type="DOI">10.2196/17883</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eR8qkua">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">17883</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Badawy SM, Shah R, Beg U, Heneghan MB. Habit Strength, Medication Adher- ence, and Habit-Based Mobile Health Interventions Across Chronic Medical Conditions: Systematic Review. J Med Internet Res. 2020;22(4):e17883.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main" xml:id="_8TtUJzp">The effect of a mobile-application tool on intrinsic motivation,perceived competence and achievement</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Vandvik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lucas M. Jeno G, JA, Vandvik, V. The effect of a mobile-application tool on intrinsic motivation,perceived competence and achievement. 2016.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title level="m" type="main" xml:id="_VQMwD47">Gamification From the Perspective of Self-Determination Theory and Flow</title>
		<author>
			<persName><forename type="first">Florian</forename><surname>Brühlmann</surname></persName>
		</author>
		<idno type="DOI">10.31237/osf.io/6kauv</idno>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Florian Brühlmann. Gamification From the Perspective of Self-Determination Theory and Flow. 2013.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_qQMqCqy">Enhancing user engagement: The role of gamification in mobile apps</title>
		<author>
			<persName><forename type="first">P</forename><surname>Bitrián</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Buil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Catalán</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jbusres.2021.04.028</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tu3TgYp">Journal of Business Research</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="170" to="185" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bitrián P, Buil I, Catalán S. Enhancing user engagement: The role of gamifica- tion in mobile apps. Journal of Business Research. 2021;132:170-85.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_d2fVWeA">The impact of gamified interaction on mobile learning APP users&apos;learning performance: the moderating effect of users&apos; learning style</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g5Dz9aq">Behaviour &amp;Information Technology</title>
		<imprint>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fan J, Wang Z. The impact of gamified interaction on mobile learning APP users&apos;learning performance: the moderating effect of users&apos; learning style. Behaviour &amp;Information Technology. 2020:1-14.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_XGdyZz4">Gamification. Encyclopedia of Information Science and Technology</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Reiners</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_MEynSAu">Advances in Information Quality and Management</title>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="page" from="3039" to="3047" />
		</imprint>
	</monogr>
	<note>Third Edition</note>
	<note type="raw_reference">Wood LC, Reiners T. Gamification. Encyclopedia of Information Science and Technology,Third Edition. Advances in Information Quality and Manage- ment2014. p. 3039-47.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_KsxpfxC">How feedback boosts motivation and play in a brain-training game</title>
		<author>
			<persName><forename type="first">C</forename><surname>Burgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Van Engelenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Buningh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NxZ6kUJ">Computers in Human Behavior</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="94" to="103" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burgers C, Eden A, van Engelenburg MD, Buningh S. How feedback boosts motivation and play in a brain-training game. Computers in Human Behavior. 2015;48:94-103.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_dEkAmC2">The relationship of trait to state motivation:the role of self-competency beliefs</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saperstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Medalia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rqv9Z7r">Schizophr Res</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="73" to="77" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Choi KH, Saperstein AM, Medalia A. The relationship of trait to state motivation:the role of self-competency beliefs. Schizophr Res. 2012;139(1-3):73-7.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main" xml:id="_Eyd27QJ">Promoting intrinsic motivation with a mobile augmented reality learning environment</title>
		<author>
			<persName><forename type="first">Josef</forename><surname>Buchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Josef Buchner JZ. Promoting intrinsic motivation with a mobile augmented reality learning environment. 2018.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_6Rpg2Gf">How to encourage intrinsic motivation in the clinical teaching environment?: a systematic review from the self-determination theory</title>
		<author>
			<persName><forename type="first">C</forename><surname>Orsini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jerez</surname></persName>
		</author>
		<idno type="DOI">10.3352/jeehp.2015.12.8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t4HayBP">J Educ Eval Health Prof</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">8</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Orsini C, Evans P, Jerez O. How to encourage intrinsic motivation in the clini- cal teaching environment?: a systematic review from the self-determination theory. J Educ Eval Health Prof. 2015;12:8.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_WS6Rs5V">Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Tola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shojaeizadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Garmaroudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Yekaninejad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kebede</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qhea6vs">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">155147</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tola HH, Shojaeizadeh D, Tol A, Garmaroudi G, Yekaninejad MS, Kebede A, et al.Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. PLoS One. 2016;11(5):e0155147.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_ANe5QnF">Impact of Physician&apos;s Education on Adherence to Tuberculosis Treatment for Patients of Low Socioeconomic Status in Bangladesh</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">F</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.4068/cmj.2013.49.1.27</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d2NGNq2">Chonnam Med J</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="30" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee S, Khan OF, Seo JH, Kim DY, Park KH, Jung SI, et al. Impact of Physician&apos;s Education on Adherence to Tuberculosis Treatment for Patients of Low Socio- economic Status in Bangladesh. Chonnam Med J. 2013;49(1):27-30.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_XCjkMhG">Advantage in privacy protection by using synchronous video observed treatment enhances treatment adherence among patients with latent tuberculosis infection</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">U</forename><surname>Putri</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jiph.2020.03.013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kHryzMZ">J Infect Public Health</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1354" to="1359" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chen SH, Wang I, Hsu HL, Huang CC, Liu YJ, Putri DU, et al. Advantage in pri- vacy protection by using synchronous video observed treatment enhances treatment adherence among patients with latent tuberculosis infection. J Infect Public Health. 2020;13(9):1354-9.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_aY5gNjh">Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zenilman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shah</surname></persName>
		</author>
		<idno type="DOI">10.1093/ofid/ofy046</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JWfPgzV">Open Forum Infect Dis</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">46</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Holzman SB, Zenilman A, Shah M. Advancing Patient-Centered Care in Tuber- culosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy. Open Forum Infect Dis. 2018;5(4):ofy046.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
